Lumefantrine
Top View
- Identification of Trypanosoma Cruzi Growth Inhibitors with Activity In
- Combination Anti-Malarial Therapy and WHO Recommendations
- WHO Guidance for Prevention and Treatment of Malaria in Pregnancy
- Pharmaceutical Composition Comprising Artesunate, Sulfamethoxypyrazine and Pyrimethamine for Use in the Treatment of Malaria
- Localization of the Human Malaria Parasite's DHFR-TS and Examining
- The Cardiotoxicity of Antimalarials
- E Cacy of Quinine Plus Clindamycin Versus Artemether-Lumefantrine
- The Medical Letter
- Antimalarial Agents
- WO 2007/028413 Al
- Lumefantrine, an Antimalarial Drug, Reverses Radiation and Temozolomide Resistance in Glioblastoma
- Study Protocol and Statistical Analysis Plan
- Belize Drug Formulary and Therapeutics Manual
- Recommendations for the Treatment and Prevention of Malaria : Update for the 2015 Season in South Africa: SAMJ March 2015 Vol 10
- Other Review(S)
- Coartem® at Cost Price to Malaria Endemic Countries Has Come to Its End
- Updated CDC Recommendations for Using Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria in Pregnant Women in the United States
- Drug Repurposing and Human Parasitic Protozoan Diseases ⇑ ⇑ Katherine T